Silence Therapeutics

In News

Silence Therapeutics to Participate in Three September Investor Conferences - Yahoo Finance

Yahoo Finance - Sep 02, 2026

Silence Therapeutics: Divesiran showed robust phase II efficacy and safety, advancing to phase III with strong financial backing - TradingView

TradingView - Sep 16, 2026

Silence Therapeutics at Morgan Stanley conference: divesiran drives focus - Investing.com

Investing.com - Sep 16, 2026

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares - Business Wire

Business Wire - Aug 10, 2026

Silence Therapeutics aims at Takeda with new data in rare blood cancer - statnews.com

statnews.com - Aug 10, 2026

Silence brings the noise to Takeda with phase 2 blood cancer win - Fierce Biotech

Fierce Biotech - Aug 10, 2026

Silence Therapeutics: Making Some Recent Noise (NASDAQ:SLN) - Seeking Alpha

Seeking Alpha - Aug 19, 2026

Silence Therapeutics at H.C. Wainwright conference: divesiran drives focus - Investing.com

Investing.com - Sep 15, 2026

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential - Yahoo Finance

Yahoo Finance - Jun 30, 2026

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering - Business Wire

Business Wire - Aug 11, 2026

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy) (NASDAQ:SLN) - Seeking Alpha

Seeking Alpha - Jul 12, 2026

Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last? - Yahoo Finance Singapore

Yahoo Finance Singapore - Jul 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment